BAXTER INTERNATIONAL INC
BAXHealthcarebaxter.com
Latest available resultsSeptember 30, 2026Quarter · 10-Q filed Oct 29, 2026
Next reportFebruary 10, 2027after close · forecast 0.602 $/share
Revenue
$2.98B
▲ +5.0% vs prior year YoY
Net income
$294.00M
▲ +739.1% vs prior year YoY
EPS
0.57$
▲ +733.3% vs prior year YoY
Net margin
9.9%
▲ +11.5 pp vs prior year YoY
Revenue▲ +5.0%
Margins (% of revenue)GrossOperatingNet
Net income▲ +739.1%
EPS▲ +733.3%
Financial statements
View 10-Q filed October 29, 2026 on SEC ↗| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $533.00M | $2.63B | $2.81B | $2.83B | $2.97B | $2.70B | $2.96B | $2.98B | ▲ +5.0% |
| Gross profit | $133.00M | $861.00M | $991.00M | $950.00M | $577.00M | $891.00M | $1.03B | $994.00M | ▲ +4.6% |
| Operating income | −$136.00M | $58.00M | $191.00M | $172.00M | −$729.00M | $66.00M | $217.00M | $225.00M | ▲ +30.8% |
| Net income | −$512.00M | $126.00M | $91.00M | −$46.00M | −$1.13B | −$15.00M | $126.00M | $294.00M | ▲ +739.1% |
| R&D | $112.00M | $140.00M | $134.00M | $118.00M | $126.00M | $139.00M | $129.00M | $125.00M | ▲ +5.9% |
| EPS (diluted) | — | 0.25 $ | 0.18 $ | -0.09 $ | — | -0.03 $ | 0.24 $ | 0.57 $ | ▲ +733.3% |
| Margins (% of revenue) | |||||||||
| Gross | 25.0 % | 32.8 % | 35.3 % | 33.5 % | 19.4 % | 33.0 % | 34.9 % | 33.4 % | ▼ -0.1 pt |
| Operating | -25.5 % | 2.2 % | 6.8 % | 6.1 % | -24.5 % | 2.4 % | 7.3 % | 7.6 % | ▲ +1.5 pt |
| Net | -96.1 % | 4.8 % | 3.2 % | -1.6 % | -37.9 % | -0.6 % | 4.3 % | 9.9 % | ▲ +11.5 pt |
| Balance sheet | |||||||||
| Assets | $25.78B | $21.30B | $21.05B | $21.07B | $20.05B | $19.85B | $19.79B | $19.41B | ▼ -7.8% |
| Liabilities | $18.76B | $14.25B | $13.75B | $13.85B | $13.95B | $13.83B | $13.61B | $12.94B | ▼ -6.6% |
| Equity | $7.02B | $7.05B | $7.29B | $7.21B | $6.10B | $6.02B | $6.18B | $6.47B | ▼ -10.2% |
| Cash | $1.76B | $2.29B | $1.69B | $1.73B | $1.97B | $2.02B | $2.15B | $1.98B | ▲ +14.4% |
| Capital | |||||||||
| Shares outstanding | 511.62M | 513.17M | 513.62M | 514.06M | 514.49M | 516.47M | 517.00M | 517.35M | ▲ +0.6% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.